At present, the development and progression of arthropathy is monitored by clinical follow-up and imaging. Many different clinical tools and imaging modalities are used for the assessment of joint health, each with its own advantages and limitations. The value of clinical assessment tools is determined by its sensitivity, inter-observer variation, floor/ ceiling effects and the appropriateness in different patient populations. Imaging modalities also have issues with